Trial Profile
Effects of add-on tiotropium bromide on exacerbations in patients with COPD
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Jan 2017
Price :
$35
*
At a glance
- Drugs Tiotropium bromide (Primary) ; Beta 2 adrenergic receptor agonists; Corticosteroids
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms OUTPUL
- 30 Apr 2014 New trial record